Inventor · disambiguated record
Zhendong Zhu
Also filed as: ZHU ZHENDONG
20 granted patents·12 pending applications·157 citations·filing 2010–2024
94Inventor score
Files withCELGENE CAR LLC12CELGENE AVILOMICS RES INC9ARTIVILA BIOPHARMA4Shenzhen Bay Laboratory2AVILA THERAPEUTICS INC1
Top patents by PatentIndex Score
32 records- 0196US9561228B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Feb 7, 2017·37 cites·17 claims
- 0294US9145387B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Sep 29, 2015·21 cites·28 claims
- 0393US9980964B2ERK inhibitors and uses thereofCELGENE CAR LLC·Filed 2017·Granted May 29, 2018·11 cites·28 claims
- 0492US9504686B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Nov 29, 2016·10 cites·40 claims
- 0592US9321786B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Apr 26, 2016·15 cites·51 claims
- 0691US9796700B2ERK inhibitors and uses thereofCELGENE CAR LLC·Filed 2016·Granted Oct 24, 2017·7 cites·17 claims
- 0790US9415049B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2013·Granted Aug 16, 2016·12 cites·27 claims
- 0889US10138256B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2014·Granted Nov 27, 2018·11 cites·12 claims
- 0988US9663524B2Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitorsCELGENE CAR LLC·Filed 2014·Granted May 30, 2017·15 cites·27 claims
- 1087US9695132B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Jul 4, 2017·5 cites·63 claims
- 1180US10189794B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2017·Granted Jan 29, 2019·2 cites·56 claims
- 1278US9556426B2Protein kinase conjugates and inhibitorsSINGH JUSWINDER·Filed 2010·Granted Jan 31, 2017·3 cites·48 claims
- 1377US10065966B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2017·Granted Sep 4, 2018·2 cites·27 claims
- 1477US9126950B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2013·Granted Sep 8, 2015·4 cites·24 claims
- 1574US10662195B2Protein kinase conjugates and inhibitorsCELGENE AVILOMICS RES INC·Filed 2016·Granted May 26, 2020·1 cites·1 claims
- 1671US10774052B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2019·Granted Sep 15, 2020·0 cites·31 claims
- 1771US2022332687A1Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2020·Application pending·0 cites
- 1869US11542492B2Ligand-directed covalent modification of proteinCELGENE CAR LLC·Filed 2017·Granted Jan 3, 2023·1 cites·7 claims
- 1963US2025346613A1Boric acid proteasome inhibitor and use thereofARTIVILA BIOPHARMA·Filed 2023·Application pending·0 cites
- 2063US2025368633A1Azepine fused ring compound as ripk1 inhibitor and use thereofARTIVILA BIOPHARMA·Filed 2023·Application pending·0 cites
- 2162US10618902B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2018·Granted Apr 14, 2020·0 cites·15 claims
- 2260US11098061B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2018·Granted Aug 24, 2021·0 cites·14 claims
- 2359US2023414581A1Sarm1 enzyme activity inhibitor and use thereof in neurodegenerative diseasesARTIVILA BIOPHARMA·Filed 2021·Application pending·0 cites
- 2458US2024308987A1Small molecule inhibitor against nasopharyngeal carcinoma, preparation method and application thereofShenzhen Bay Laboratory·Filed 2024·Application pending·0 cites
- 2557US2025346592A1Heterocyclic pad4 inhibitorsCELGENE CORP·Filed 2023·Application pending·0 cites
- 2657US2024368168A1Sarm1 enzyme activity inhibitor and application thereofARTIVILA BIOPHARMA·Filed 2022·Application pending·0 cites
- 2754US2023157996A1Small-molecule inhibitor targeting eb virus nuclear antigen protein, preparation method and use thereofShenzhen Bay Laboratory·Filed 2022·Application pending·0 cites
- 2851US2017095475A1Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2016·Application pending·0 cites
- 2949US2024391960A1Extracellular cyclophilin inhibitor and use thereofUNIV PEKING SHENZHEN GRADUATE SCHOOL·Filed 2021·Application pending·0 cites
- 3047US2011269244A1Ligand-directed covalent modification of proteinPETTER RUSSELL C·Filed 2010·Application pending·0 cites
- 3142US9549927B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Jan 24, 2017·0 cites·25 claims
- 3236US2011230476A1Pi3 kinase inhibitors and uses thereofAVILA THERAPEUTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhendong Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →